Covid boosters to be offered to over 40s


Share post:

Britain’s booster programme for Covid-19 vaccinations is set to be expanded following advice from scientists.

The government’s Joint Committee on Vaccination and Immunization (JCVI) said today (November 15) that all healthy adults aged 40-49 should be offered a booster, six months after their second dose.

Previously, the booster programme was limited to those aged 50 and over, and the clinically vulnerable.

So far, some 12.6 million people have had a booster dose.

The latest advice comes after the UK Health Security Agency released data from a real-world study which found the booster gave over 90 per cent protection against symptomatic Covid-19 for people aged 50 years and older.

The JCVI also said that 16 and 17 year olds, who were initially offered only a single dose, should now get a second.

Professor Wei Shen Lim, chair, Covid-19 immunisation, JCVI said: “Booster vaccine doses in more vulnerable adults, and second vaccine doses in 16 – 17 year olds are important ways to increase our protection against Covid-19 infection and severe disease. These vaccinations will also help extend our protection into 2022.”

Following JCVI advise the UK has been using either the Pfizer-BioNTech vaccine, or the Moderna vaccine in the booster rollout.

The Medicines and Healthcare products Regulatory Agency (MHRA) has maintained that booster doses are safe and side-effects, if any, are either a sore arm or flu-like symptoms.

MHRA chief executive Dr June Raine welcomed JCVI’s announcement on the extension of the booster campaign to 40-49 year olds.

“This further strengthens our ability to ensure people are protected against Covid-19 and saves lives. Our proactive monitoring of the safety of booster doses does not raise any new concerns,” she said.


Please enter your comment!
Please enter your name here

Current Issue October 2023

Related articles

England lost more than 1,000 pharmacies in the last eight years, says CCA

Community pharmacies are currently facing a worrying mix of funding, workforce, and workload pressures The Company Chemists’ Association...

NHS care delays led to 112 deaths, harmed 8,000 people in England last year

The number of patients dying due to care delays have risen more than fivefold over the last three...

Whitworth Chemists puts six high-dispensing Blackpool pharmacies up for sale

The family-owned business has decided to sell all 34 pharmacies across the North of England Whitworth Chemists Limited...

Babies born with Wolman disease can now receive a life-saving treatment on the NHS

The new enzyme replacement therapy improves patient’s life expectancy and quality of life in clinical trials   For the first...